Authors:
van Boxel-Dezaire, AHH
van Trigt-Hoff, SCJ
Killestein, J
Schrijver, HM
van Houwelingen, JC
Polman, CH
Nagelkerken, L
Citation: Ahh. Van Boxel-dezaire et al., Contrasting responses to interferon beta-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?, ANN NEUROL, 48(3), 2000, pp. 313-322
Authors:
Steyerberg, EW
Eijkemans, MJC
van Houwelingen, JC
Lee, KL
Habbema, JDF
Citation: Ew. Steyerberg et al., Prognostic models based on literature and individual patient data in logistic regression analysis, STAT MED, 19(2), 2000, pp. 141-160
Authors:
van Boxel-Dezaire, AHH
Hoff, SCJ
van Oosten, BW
Verweij, CL
Drager, AM
Ader, HJ
van Houwelingen, JC
Barkhof, F
Polman, CH
Nagelkerken, L
Citation: Ahh. Van Boxel-dezaire et al., Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis, ANN NEUROL, 45(6), 1999, pp. 695-703
Authors:
de Bock, GH
Reijneveld, SA
van Houwelingen, JC
Knottnerus, JA
Kievit, J
Citation: Gh. De Bock et al., Multiattribute utility scores for predicting family physicians' decisions regarding sinusitis, MED DECIS M, 19(1), 1999, pp. 58-65
Authors:
Kapiteijn, E
Marijnen, CAM
Colenbrander, AC
Kranenbarg, EK
Steup, WH
van Krieken, JHJM
van Houwelingen, JC
Leer, JWH
van de Velde, CJH
Citation: E. Kapiteijn et al., Local recurrence in patients with rectal cancer diagnosed between 1988 and1992: a population-based study in the west Netherlands, EUR J SUR O, 24(6), 1998, pp. 528-535